Use of acetylsalicylic acid in secondary prevention of stroke

International Journal of Clinical Practice, Supplement

Volumn , Issue 97, 1998, Pages 12-15

  Diener, Hans Christoph ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; DIPYRIDAMOLE;

BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; DIGESTIVE SYSTEM FUNCTION DISORDER; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT; SECONDARY PREVENTION; STROKE; TRANSIENT ISCHEMIC ATTACK;

EID: 33749296262     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Fields WS, Lemak N, Frankowski F, Hardy RJ. Controlled trial of aspirin in cerebral ischemia. Part II. Stroke 1978; 9: 309-319.
2. Fields WS, Lemak NA, Frankowski RF, Hardy RJ. Controlled trial of aspirin in cerebral ischemia. Stroke 1977; 8: 301-316.
3. Reuther RD, Dorndorf W. Aspirin in patients with cerebral ischemia and normal angiograms or non-surgical lesions. In: Breddin KD, Loew D, Marx R (eds). Acetylsalicylic acid in cerebral ischemia and coronary heart disase. Stuttgart: Schattauer 1978; 97-106.
4. Canadian Cooperative Study Group. A randomized trial of aspirin and sulfinpyrazone in threatened stroke. N Engl J Med 1978; 299: 53-59.
5. Guiraud-Chaumeil B, Rascol A, David J et al. Prevention des récidives des accidents vasculaires cérébraux ischémiques par les anti-agrégants plaquettaires. Rev Neurol (Paris) 1982; 138: 367-385.
6. Bousser MG, Eschwege E, Haguenau M et al. 'AICLA' controlled trial of aspirin and dipyridamole in the secondary prevention of atherothrombotic cerebral ischemia. Stroke 1983; 14: 5-14.
7. Sorensen PS, Pedersen H, Marquardsen J et al. Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study. Stroke 1983; 14: 15-22.
8. A Swedish Cooperative Study. High-dose acetylsalicylic acid after cerebral infarction. Stroke 1987; 18: 325-334.
9. UK TIA Study Group. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991; 54: 1044-1054.
10. The SALT Collaborative Group. Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 1991; 338: 1345-1349.
11. Diener HC, Cunha L, Forbes C et al. European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996; 143: 1-13.
12. Algra A, van Gijn J. Aspirin at any dose above 30 mg offers only modest protection after cerebral ischaemia. J Neurol Neurosurg Psychiatry 1996; 60: 197-199.
13. Antiplatelet Trialist's collaboration. Collaborative overview of randomised trials of antiplatelet therapy-I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106.
14. The Dutch TIA Trial Study Group. A comparison of two doses of aspirin (30 mg vs 283 mg a day) in patients after a transient ischaemic attack or minor ischaemic stroke. N Engl J Med 1991; 338:1345-1349.
15. Diener HC, Forbes C, Riekkinen PJ et al and the ESPS Group. European Stroke Prevention Study 2: Efficacy and safety data. J Neurol Sci 1997; 151: S1-S77.
16. CAPRIE Steering Committee. A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-1339.